Analysis

Medicines Discovery Catapult: improving collaborative drug discovery in the UK

Medicines Discovery Catapult: improving collaborative drug discovery in the UK

Therapeutic orphans: child-friendly drugs and the quest for adherence

Therapeutic orphans: child-friendly drugs and the quest for adherence

A peptide to prevent pre-diabetes

A peptide to prevent pre-diabetes

The Hive: new incubator makes a beeline for non-traditional pharma companies

The Hive: new incubator makes a beeline for non-traditional pharma companies

Tackling false trial data in China

Tackling false trial data in China

Pfizer’s big antibiotic buyout: a sign of things to come?

Pfizer’s big antibiotic buyout: a sign of things to come?

Plague, Flu and Zika: could 2017 bring vaccines for all three?

Plague, Flu and Zika: could 2017 bring vaccines for all three?

Bringing together Oxford and Cambridge’s biopharma clusters

Bringing together Oxford and Cambridge’s biopharma clusters

IBM’s lab on a chip breakthrough seeks out cancers origin

IBM’s lab on a chip breakthrough seeks out cancers origin

US Precision Medicine Initiative gears up for a massive e-health drive

US Precision Medicine Initiative gears up for a massive e-health drive

Going global: India’s big biosimilar move

Going global: India’s big biosimilar move

Is the stage set for global drug price regulation?

Is the stage set for global drug price regulation?

Pharma Technology Focus – Issue 50

Pharma Technology Focus – Issue 50

Xilonix: new anti-tumour cancer drug is on the fast-track

Xilonix: new anti-tumour cancer drug is on the fast-track

ChemoFilter: getting the drugs back out

ChemoFilter: getting the drugs back out

Psilocybin vs. depression: London study overcomes obstacles to show encouraging results

Psilocybin vs. depression: London study overcomes obstacles to show encouraging results

Watching the clock: should day and night influence our drug regimens?

Watching the clock: should day and night influence our drug regimens?

July's top stories: Cancer Drugs Fund implemented in UK, Nichi-Iko acquired Sagent Pharmaceuticals

July's top stories: Cancer Drugs Fund implemented in UK, Nichi-Iko acquired Sagent Pharmaceuticals

Tackling counterfeit Viagra

Tackling counterfeit Viagra

Nurturing an African pharma boom

Nurturing an African pharma boom

The drug company tackling disease in Lebanon’s packed refugee camps

The drug company tackling disease in Lebanon’s packed refugee camps
cachename:Featurescachekey:rd-137342983_-954009584_rd-1665407042_727740091_rd-488908060_1460672566_ap1460672566_727740091_971827490